Our Platforms
STCC's five integrated cancer research platforms support investigators, researchers and industry partners with clinical trial infrastructure, cancer data and tissue resources, translational research expertise, industry collaboration opportunities, and population health insights. Together, they accelerate cancer discovery, innovation and implementation across Singapore's healthcare ecosystem to improve patient and societal outcomes.
Last updated 6 July 2026
Explore STCC's Five Integrated Cancer Research Platforms
Cancer Clinical Trials & Investigational Medicine Units
Streamline clinical trial start-up framework and facilitate multi-site investigator-initiated trials across three healthcare clusters in Singapore.
Cancer Databases & Tissue Banks
Provision of governed access to high-quality, Asian-centric multi-modal cancer data to enable translational research, AI model development and validation across Singapore’s healthcare system.
Translational Research Integration & Support
Bringing together expertise from cancer research institutes and academic centres across Singapore through a comprehensive facilitative pipeline for translational and pre-clinical research
Business Intelligence & Development
As STCC’s dedicated business team for active industry engagements, the platform develops outreach strategies and is a single contact point to industry partners interested in cancer-related clinical and research collaborations.
Impact & Population Health
Support data generation and assessment relevant to health impact to inform policy change and implementation aligned with value-based cancer care.